Beneficial effects of voglibose administration on body weight and lipid metabolism via gastrointestinal bile acid modification
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Do, Hyun Ju | - |
dc.contributor.author | Lee, Youn Sue | - |
dc.contributor.author | Ha, Min Jin | - |
dc.contributor.author | Cho, Yoonsu | - |
dc.contributor.author | Yi, Hana | - |
dc.contributor.author | Hwang, Yu-Jin | - |
dc.contributor.author | Hwang, Geum-Sook | - |
dc.contributor.author | Shin, Min-Jeong | - |
dc.date.accessioned | 2021-09-03T21:02:03Z | - |
dc.date.available | 2021-09-03T21:02:03Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-08-20 | - |
dc.identifier.issn | 0918-8959 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87797 | - |
dc.description.abstract | This study was designed with the goal of examining the effects of voglibose administration on body weight and lipid metabolism and underlying mechanism high fat diet-induced obese mice. Male C57BL/6 mice were randomly assigned to one of four groups: a control diet (CTL), high-fat diet (HF), high-fat diet supplemented with voglibose (VO), and high fat diet pair-fed group (PF). After 12 weeks, the following characteristics were investigated: serum lipid and glucose levels, serum polar metabolite profiles, and expression levels of genes involved in lipid and bile acid metabolism. In addition, pyrosequencing was used to analyze the composition of gut microbiota found in feces. Total body weight gain was significantly lower in the VO group than in the CTL, HF, and PF groups. The VO group exhibited improved metabolic profiles including those of blood glucose, triglyceride, and total cholesterol levels. The 12-week voglibose administration decreased the ratio of Firmicutes to Bacteroidetes found in feces. Circulating levels of taurocholic and cholic acid were significantly higher in the VO group than in the HF and CTL groups. Deoxycholic acid levels tended to be higher in the VO group than in the HF group. Voglibose administration downregulated expression levels of CYP8B1 and I-INF4 alpha genes and upregulated those of PGC1 alpha, whereas FXR alpha was not affected. Voglibose administration elicits changes in the composition of the intestinal microbiota and circulating metabolites, which ultimately has systemic effects on body weight and lipid metabolism in mice. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | JAPAN ENDOCRINE SOC | - |
dc.subject | DIET-INDUCED OBESITY | - |
dc.subject | GUT MICROBIOTA | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | RECEPTOR FXR | - |
dc.subject | MICE | - |
dc.subject | HOST | - |
dc.subject | CHOLESTEROL | - |
dc.subject | MECHANISMS | - |
dc.subject | GLUCOSE | - |
dc.subject | TISSUE | - |
dc.title | Beneficial effects of voglibose administration on body weight and lipid metabolism via gastrointestinal bile acid modification | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yi, Hana | - |
dc.contributor.affiliatedAuthor | Shin, Min-Jeong | - |
dc.identifier.scopusid | 2-s2.0-84984905718 | - |
dc.identifier.wosid | 000382797700003 | - |
dc.identifier.bibliographicCitation | ENDOCRINE JOURNAL, v.63, no.8, pp.691 - 702 | - |
dc.relation.isPartOf | ENDOCRINE JOURNAL | - |
dc.citation.title | ENDOCRINE JOURNAL | - |
dc.citation.volume | 63 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 691 | - |
dc.citation.endPage | 702 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | DIET-INDUCED OBESITY | - |
dc.subject.keywordPlus | GUT MICROBIOTA | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | RECEPTOR FXR | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | HOST | - |
dc.subject.keywordPlus | CHOLESTEROL | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.subject.keywordPlus | TISSUE | - |
dc.subject.keywordAuthor | Voglibose | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Lipid metabolism | - |
dc.subject.keywordAuthor | Bile acid | - |
dc.subject.keywordAuthor | Microbiome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.